Skip to main content

About Xanadu

A company built from a personal loss and a decade of clinical safety work at Providence. Not a pivot. Not a trend. A mission.

Why this work exists

In 2007, the founder of Xanadu lost his wife seven days after she delivered their third daughter, due to mistakes in her data. The warning signs were there. They never made it up the chain. Rather than walk away from healthcare, he joined it to help make a difference and prevent this from happening to others.

In 2010 he joined Providence then Opala, and combined has spent the last 16 years building the clinical safety systems that prevent the failure that killed his family: MEWS (Modified Early Warning Score) and real-time SEPSIS alerting at Providence Health System, validated in Epic, now standard of care. A Defect Prevention Governance framework that secured $13 million in annual risk avoidance with zero critical defects introduced into production over fifteen years.

Xanadu is the engineering distillation of that work. Patient data ownership, privacy, and control are not abstract regulatory concerns. They are a moral commitment, rooted in lived experience, applied as testable artifacts.

Founded on the conviction that healthcare data ownership is a patient right, not a regulatory checkbox. Built so families don't have to fight the system to control their own health data.

Terry Virdell, Founder

A decade of clinical safety work at Providence

MEWS
Early Warning & Bedboard Tracking

From 2010 to 2013, helped build, deploy, and train clinicians on Modified Early Warning Score (MEWS) monitoring and Bedboard Tracking tools at Providence -- flagging patient deterioration before it becomes a crisis and giving care teams real-time bed and acuity visibility.

SEPSIS
Sepsis, CAUTI, CLABSI & Readmission

Helped deliver Providence's Sepsis alerting, CAUTI and CLABSI surveillance, and Readmission Tracking tools -- the infection-prevention and post-discharge feedback loops that reduce avoidable harm and avoidable returns.

$13M
Defect Prevention at Scale

Later at Providence (Senior Manager then Director), led a 30-plus person QA and automation department covering ~250 application and hardware projects per year. Built the QA training program and trained 1,300-plus analysts, PMs, and managers on ISTQB best practices. Team-documented prevention work caught approximately 2,600 critical and high-severity defects annually before production -- approximately $13M/year in risk avoidance at a conservative $5,000-per-defect remediation cost. Reported in annual leadership reviews 2018-2020. Emily Gamelin Award for Excellence, April 2020.

B Corp framing

Xanadu is structured to create stakeholder value, not just shareholder value. These are the commitments that shape every business decision.

Accessible pricing

Healthcare and education are human rights. Xanadu's pricing is designed to be accessible to organizations that cannot afford Big 4 consulting rates. The Sovereignty Scorecard audits are priced for community health centers and lean startups, not just enterprise payers.

Patient-centered economics

The 80/20 Payout is a B Corp principle made concrete: when the platform generates revenue from member data, the members benefit more than the platform. This is the inverse of the current industry norm.

No surveillance, no tracking

Consistent with EFF guidance: no analytics, no ad networks, no tracking pixels on any Xanadu property. We practice what we audit others for violating.

Open standards

We prefer open standards and open-source tools wherever they meet our clinical quality bar. FHIR is open. HL7 is open. Data portability means data freedom, not vendor lock-in.

Want to work with us or join the trust?

Get on the waitlist, or reach out directly at terry@yourdata.health.

Join the waitlist